S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Sanchez Energy Provides Interim Update Regarding the Company's Current Financial Position and Recent Operations Activity (2014/12/10)|
|Immunomedics Awarded Fast Track Designation by FDA for Sacituzumab Govitecan (IMMU-132) for Triple-Negative Breast Cancer Therapy|
|Immunomedics Announces European Orphan Drug Designation for Isactuzumab Govitecan for Pancreatic Cancer Treatment|
|Sanchez Energy Announces Record Third Quarter 2014 Production of 3,552 MBOE, an Increase of 91% Over Second Quarter 2014 and an Increase of 228% Over the Third Quarter 2013, and Provides Operations Update (2014/10/23)|
|Sanchez Energy Announces Third Quarter 2014 Financial Results and Updates Operations; Record Third Quarter Revenues Rise 37% on 91% Higher Production Compared to Previous Quarter Results (2014/11/4)|
|International study shows incisions managed with unique PICO◊ NPWT System demonstrated significantly fewer healing complications and improved scar quality in bilateral breast reduction patients|
|Energen Raises CY14 Production Guidance Midpoint by 500 MBOE|
|Video Release -- Preclinical Research Differentiating the Activity of Merrimack's MM-398, Nanoliposomal Irinotecan (nal-IRI), Published in Cancer Research|
|Immunomedics Provides Update on Phase 2 Study of Isactuzumab Govitecan in Patients With Diverse Metastatic Solid Cancers|
|Stifel Reports Third Quarter 2014 Financial Results (2014/11/6)|
Click above to view more mutual fund data and stats for sn - Sennen Potash Corp.